Effect of bromocriptine in diabetes treatment
Phase 2
- Conditions
- Type 2 diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201204156710N3
- Lead Sponsor
- Vice chancellor for research of Tabriz University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All type 2 diabetes patients who do not have exclusion criteria. Exclusion criteria:
1- Age lower than 30 and more than 65;
2- HbA1C lower than 7.5% and more than 9%;
3- Patients who are not willing to participate;
4- Pregnant patients and lactating patients;
5- Syncope attacks;
6- Severe psychosis;
7- Sensitive to bromocriptine and ergot drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood sugar. Timepoint: 1.5 months. Method of measurement: lab tests.
- Secondary Outcome Measures
Name Time Method ipid profile. Timepoint: 3 and 6 months. Method of measurement: lab tests.